ClinicalTrials.Veeva

Menu

Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Unknown

Conditions

Heart Surgery

Treatments

Procedure: Left atrial appendage occlusion surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04108169
20190926

Details and patient eligibility

About

This is a prospective, single-center, randomized, active controlled, clinical trail to assess the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients undergoing coronary artery bypass graft.

Enrollment

240 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject undergoing coronary artery bypass grafting according to clinical indications;
  2. Age is more than 18 and less than 80 years old;
  3. Male and non pregnancy female;
  4. Subject understands study requirements and agrees to sign an informed consent from prior to study procedures.

Exclusion criteria

  1. Pregnancy female;
  2. Participate in other clinical trial in the last 1 month.
  3. Subject doesn't agree to sign an informed consent from prior to study procedures.
  4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.
  5. New York Heart Association (NYHA) Class IV heart failure.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

240 participants in 2 patient groups

Active Comparator
Active Comparator group
Treatment:
Procedure: Left atrial appendage occlusion surgery
Sham Comparator
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Ping Li, PHD; Yulin Li, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems